About: ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1991

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1991 (uk) article scientifique publié en 1991 (fr) im Juni 1991 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1991 (ast) scientific article published on 01 June 1991 (en)
publication date	wds:Q70178712-4D573872-2DB8-4839-8BFA-EB7E72BA4F5B
publication date	1991-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70178712-03D4B772-A9CA-4969-A3DD-E7316548B3F0
language of work or name	English
author name string	wds:Q70178712-01C79F53-8D94-4404-BA90-0802094C1169 wds:Q70178712-2190A39D-DE35-4141-A900-ED0C87C846B5 wds:Q70178712-285AD37F-0D59-4B38-8C88-889B53705F68 wds:Q70178712-5EA5F07C-A34D-4B54-8007-87756C679797 wds:Q70178712-8D94F327-737F-4FF5-B8CD-7C2EE471243A wds:Q70178712-9DE8D83F-ECFF-4E3F-A966-44B97BBE3ACD wds:Q70178712-BAECCB15-9F46-425B-BEBB-E7A712F4DFE7 wds:Q70178712-EA5D8D57-CBD3-438E-8315-CD7B3C93F8BF wds:Q70178712-F21EEF06-B471-4D9F-AD8D-B4AB9B5E6D87
author name string	J D Cox P Rubin H Ortiz H Selim M Mohiuddin K K Fu V A Marcial T F Pajak L Coia
rdfs:label	ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 (en) ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 (nl)
skos:prefLabel	ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 (en) ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 (nl)
name	ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 (en) ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 (nl)
title	wds:Q70178712-8D513408-E6DA-4EF6-B72A-C9106A9A4E83
title	ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 (en)
page(s)	wds:Q70178712-18F57ABE-EA21-4CA7-86B6-DDCA4ACF73FC
page(s)	1191-1195
instance of	wds:Q70178712-EB17749D-5FF8-4F7A-B017-1F51232402E8
instance of	scholarly article
PubMed ID	wds:Q70178712-F68BB14B-999F-41AE-B34B-FBF70B523D53
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2045293
PubMed ID	2045293
published in	wds:Q70178712-07937D13-8E33-46FC-8F00-96BF38A899D6
published in	International Journal of Radiation Oncology Biology Physics
issue	wds:Q70178712-24EE7212-80ED-4621-A04B-972AB4A7C19C
volume	wds:Q70178712-FA0F4EF4-2BED-467A-8BC3-04BF40958D9A
issue	6
volume	20
DOI	wds:Q70178712-BE766BBD-12D2-4BD9-8649-0243B851FC51
DOI	http://dx.doi.org/10.1016/0360-3016(91)90227-U
DOI	10.1016/0360-3016(91)90227-U
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70178712
is cites work of	Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients Hyperfractionation: where do we stand? A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma Altered fractionation: limited by mucosal reactions? Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck Toxicity antagonists in head and neck cancer Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). Pulsed dose rate brachytherapy Pulsed-dose-rate brachytherapy: design of convenient (daytime-only) schedules Radiotherapy for cancer of the head and neck: altered fractionation regimens Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations. Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer Na+, K+-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses. Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer
is cites work of	wds:Q37192956-A210FAC3-AF2B-4F02-A47C-BA9C25CFB055 wds:Q41482096-FC36E99B-B942-471C-8E1F-4E8701207E87 wds:Q39042012-3F04D226-EC2C-4560-A9E1-DFC5E7EFC6F6 wds:Q52207725-8896B770-A8FA-4947-8A12-73C97908846E wds:Q73090104-9DB3D038-A460-4A37-9031-5942F3382108 wds:Q49145977-B5414CA2-06C1-4B56-A565-D1D195DA9A1E wds:Q44274009-6BBE7F8E-0A35-4E26-A37A-630D63F57A66 wds:Q31992287-1342281E-8001-4C2D-9ABD-9BE4AC56FA82 wds:Q41028138-B6E73108-420F-4BEB-9CD9-3FFF4F3EAF30 wds:Q43622605-A7E086C6-0105-40F3-B953-214B3D50D76B wds:Q47644709-65B953A1-B9B6-47DB-A820-204ABECD572C wds:Q77748079-C02C3208-1AA8-48C7-BA49-F1CB10FA09D4 wds:Q70578727-BBD75F43-FA48-4F52-944E-CF005F50A9F8 wds:Q73497493-DC59FB12-3AC2-4A9E-9FCB-05C37850E7A5 wds:Q34992802-DB8C8BE7-A3A2-4263-92F5-55C644C02ADC wds:Q24235741-F123A486-21B6-4D7A-AF17-F8E30273F788 wds:Q56532851-2F369E86-2203-4452-940C-378C320FFAA5 wds:Q33678509-7F1D4E52-9028-4B05-99C5-52E3FE74C305 wds:Q40815255-D420C6A4-53DC-4E99-8F30-609E1A65A447 wds:Q55035025-6E340C40-85EB-4D45-92C7-DC9E25194F99 wds:Q40939020-3FEE8643-4B6B-4ABB-949E-C5DD6ABBE7B8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software